Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400988

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400988

Asia Pacific Plasma Derived Therapy Market, By Product, By Application, By End-User, and By Country - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

PUBLISHED:
PAGES: 267 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

Asia Pacific Plasma Derived Therapy Market size was valued at USD 130.5 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.

Life-saving medications called plasma-derived therapies are used to treat a variety of uncommon illnesses, including PIDs. They are created using plasma from donated human beings. Specialized biologic medications known as plasma-derived medicines are used to treat patients with dysfunctions and deficits in plasma proteins. Therapies produced from plasma replace lost or insufficient proteins, enabling people to live longer, healthier lives.

Plasma Derived Therapy Market- Market Dynamics

Increasing prevalence of uncommon diseases and demand for advanced technology in disease treatment are expected to propel market demand

The prevalence of rare diseases has significantly increased, necessitating the employment of specialized therapeutic interventions like plasma-derived therapy. The COVID-19 outbreak served as an illustration of a rare disease that was tried to be treated using plasma-derived therapy. The growing number of persons with genetic abnormalities has put future generations at risk because these individuals' conditions may worsen when they have children. As a result, the health care industry needs cutting-edge technologies in the therapeutic field. Furthermore, there is now a greater than ever need for cutting edge solutions to address genetic problems. However, the use of advanced treatment raises the total cost of treatment and so imposes an additional pressure on the people.

Plasma Derived Therapy Market- Key Insights

As per the analysis shared by our research analyst, the Asia Pacific market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2023-2030)

Based on Product segmentation, immunoglobulin segment was predicted to show maximum market share in the year 2022, increasing demand of the plasma derived component are fueling the market growth.

Based on Application segmentation, hemophilia was the leading market in 2022, due to high demand from disease related to blood clotting or bleeding.

Based on End-User segmentation, hospitals was the leading market in 2022, due to increasing demand for pesticides to improve the quality of plants and seeds.

On the basis of country, China held significant revenue share in 2022 mainly due to the growing healthcare sector and rising healthcare expenditure.

Plasma Derived Therapy Market- Segmentation Analysis:

The Asia Pacific Plasma Derived Therapy Market is segmented on the basis of Product, Application, End-User, and Region.

The market is divided into four categories based on Product: immunoglobulin, coagulation factors, albumin, others. The immunoglobulin dominates the market. The Increasing awareness among the people regarding the advanced procedures is proliferating the need for immunoglobulin therapy.

The market is divided into four categories based on Application: hemophilia, primary immunodeficiency disease, idiopathic thrombocytopenic purpura, others. The hemophilia dominates the market and is likely to maintain its dominance during the forecast period. The high demand for the need of advanced technologies in the therapeutic field is driving the market growth.

The market is divided into three categories based on End-User: hospitals, ambulatory surgical centers, and others. Hospitals segment held the largest share in 2022. The segment is expected to witness significant growth owing to rising advancement and investment in healthcare infrastructure is mainly boosting the market growth.

Plasma Derived Therapy Market- Country Insights

Country wise, this market is widespread into India, China, South Korea, Japan, Australia, Thailand, Indonesia, Philippines, Malaysia, Taiwan, Vietnam, Hong Kong, New Zealand, Singapore, Myanmar, and the rest of the Asia-Pacific (APAC) region.

Plasma Derived Therapy Market- Competitive Landscape:

The Asia-Pacific market is witnessing significant growth owing to development in healthcare infrastructure which is contributing majorly to market growth. Market participants are undertaking different strategies to significantly increase their market's size. Growing public knowledge of the advantages of medicines derived from plasma has contributed to the market's notable revenue growth over time. The government and major industry participants have launched numerous beneficial programs to promote blood donation, which will further bolster the market growth.

Recent Developments:

In March 2023, Takeda Pharmaceutical Company Limited has planned to invest $770 million for plasma-derived therapy plant in Japan to expand their market position.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

ASIA PACIFIC PLASMA DERIVED THERAPY MARKET KEY PLAYERS

CSL Ltd.

Takeda Pharmaceutical Company Limited

BPL

ADMA Biologics

Biotest AG

Octapharma

Grifols

Kamada Pharmaceuticals

SK Plasma

Kedrion

Pfizer

Others

ASIA PACIFIC PLASMA DERIVED THERAPY MARKET, BY PRODUCT

Immunoglobulin

Coagulation factors

Albumin

Others

ASIA PACIFIC PLASMA DERIVED THERAPY MARKET, BY APPLICATION

Hemophilia

Primary immunodeficiency disease

Idiopathic thrombocytopenic purpura

Others

ASIA PACIFIC PLASMA DERIVED THERAPY MARKET, BY END-USER

Hospitals

Ambulatory Surgical Centers

Others

ASIA PACIFIC PLASMA DERIVED THERAPY MARKET, BY REGION

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Malaysia

Taiwan

Vietnam

Hong Kong

New Zealand

Singapore

Myanmar

Rest of APAC

Product Code: ANV1952

Table of Contents

1. Asia Pacific Plasma Derived Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Asia Pacific Plasma Derived Therapy Market Snippet by Product
    • 2.1.2. Asia Pacific Plasma Derived Therapy Market Snippet by Application
    • 2.1.3. Asia Pacific Plasma Derived Therapy Market Snippet by End-User
    • 2.1.4. Asia Pacific Plasma Derived Therapy Market Snippet by Country
    • 2.1.5. Asia Pacific Plasma Derived Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Derived Therapy Key Market Trends

  • 3.1. Asia Pacific Plasma Derived Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Asia Pacific Plasma Derived Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Asia Pacific Plasma Derived Therapy Market Opportunities
  • 3.4. Asia Pacific Plasma Derived Therapy Market Future Trends

4. Plasma Derived Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Asia Pacific Plasma Derived Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Asia Pacific Plasma Derived Therapy Market Landscape

  • 6.1. Asia Pacific Plasma Derived Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Asia Pacific Plasma Derived Therapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Immunoglobulin
    • 7.1.3. Coagulation factors
    • 7.1.4. Albumin
    • 7.1.5. Others

8. Asia Pacific Plasma Derived Therapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hemophilia
    • 8.1.3. Primary immunodeficiency disease
    • 8.1.4. Idiopathic thrombocytopenic purpura
    • 8.1.5. Others

9. Asia Pacific Plasma Derived Therapy Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Others

10. Asia Pacific Plasma Derived Therapy Market- By Country

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Country, 2022 & 2030 (%)
  • 10.2. Asia Pacific
    • 10.2.1. Overview
    • 10.2.2. Plasma Derived Therapy Key Manufacturers in Asia Pacific
    • 10.2.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. India
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. China
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.9. South Korea
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.9.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.10. Japan
      • 10.2.10.1. Overview
      • 10.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.10.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.11. Australia
      • 10.2.11.1. Overview
      • 10.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.12. Thailand
      • 10.2.12.1. Overview
      • 10.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.13. Indonesia
      • 10.2.13.1. Overview
      • 10.2.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.14. Philippines
      • 10.2.14.1. Overview
      • 10.2.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.15. Malaysia
      • 10.2.15.1. Overview
      • 10.2.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.15.3. Malaysia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.15.4. Malaysia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.15.5. Malaysia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.16. Taiwan
      • 10.2.16.1. Overview
      • 10.2.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.16.3. Taiwan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.16.4. Taiwan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.16.5. Taiwan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.17. Vietnam
      • 10.2.17.1. Overview
      • 10.2.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.17.3. Vietnam Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.17.4. Vietnam Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.17.5. Vietnam Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.18. Hong Kong
      • 10.2.18.1. Overview
      • 10.2.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.18.3. Hong Kong Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.18.4. Hong Kong Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.18.5. Hong Kong Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.19. New Zealand
      • 10.2.19.1. Overview
      • 10.2.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.19.3. New Zealand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.19.4. New Zealand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.19.5. New Zealand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.20. Singapore
      • 10.2.20.1. Overview
      • 10.2.20.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.20.3. Singapore Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.20.4. Singapore Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.20.5. Singapore Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.21. Myanmar
      • 10.2.21.1. Overview
      • 10.2.21.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.21.3. Myanmar Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.21.4. Myanmar Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.21.5. Myanmar Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.22. Rest of APAC
      • 10.2.22.1. Overview
      • 10.2.22.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.22.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.22.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.22.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Asia Pacific Plasma Derived Therapy Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. CSL Ltd.
    • 11.2.2. Takeda Pharmaceutical Company Limited
    • 11.2.3. BPL
    • 11.2.4. ADMA Biologics
    • 11.2.5. Biotest AG
    • 11.2.6. Octapharma
    • 11.2.7. Grifols
    • 11.2.8. Kamada Pharmaceuticals
    • 11.2.9. SK Plasma
    • 11.2.10. Kedrion
    • 11.2.11. Pfizer
    • 11.2.12. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
Product Code: ANV1952

List of Tables

  • TABLE List of data Applications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Asia Pacific Plasma Derived Therapy Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Asia Pacific Plasma Derived Therapy Market, by Product Type 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Asia Pacific Plasma Derived Therapy Market, by Application 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Asia Pacific Plasma Derived Therapy Market, by End-User 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market: Country snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Asia Pacific Plasma Derived Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE India Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE India Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE India Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE China Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE China Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE China Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE South Korea Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE South Korea Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE South Korea Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Japan Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Japan Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Japan Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Australia Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Australia Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Australia Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Thailand Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Thailand Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Thailand Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Indonesia Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Indonesia Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Indonesia Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Phillipines Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Phillipines Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Phillipines Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Malaysia Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Malaysia Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Malaysia Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Taiwan Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Taiwan Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Taiwan Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Vietnam Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Vietnam Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Vietnam Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Hong Kong Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Hong Kong Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Hong Kong Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE New Zealand Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE New Zealand Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE New Zealand Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Singapore Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Singapore Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Singapore Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Myanmar Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Myanmar Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Myanmar Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)
  • TABLE Rest of APAC Plasma Derived Therapy Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Rest of APAC Plasma Derived Therapy Market, by Application, 2018-2030 (USD Million)
  • TABLE Rest of APAC Plasma Derived Therapy Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Asia Pacific Plasma Derived Therapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Country segment market share analysis, 2022 & 2030
  • FIGURE Country segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE India Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE China Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE South Korea Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Japan Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Australia Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Thailand Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Indonesia Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Phillipines Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Malaysia Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Taiwan Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Vietnam Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Hong Kong Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE New Zealand Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Singapore Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Myanmar Plasma Derived Therapy Market share and leading players, 2022
  • FIGURE Rest of APAC Plasma Derived Therapy Market share and leading players, 2022
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!